COMMUNIQUÉS West-GlobeNewswire

Apellis Pharmaceuticals’ APL-2 Receives Fast Track Designation from FDA for the Treatment of Patients with Geographic Atrophy
24/07/2018
CRESTWOOD, Ky., and WALTHAM, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Marrone Bio Innovations, Inc. to Present at the Jefferies 2018 Global Industrials Conference in New York
24/07/2018
DAVIS, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Maple Leaf Green World Inc. Announces Cultivation and Extraction Teams in British Columbia and Nevada
24/07/2018
CALGARY, Alberta, July 24, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“Maple Leaf”, “MGW,” or the “Company”) (NEO:MGW) (OTCQX:MGWFF) is pleased to announce the cultivation and extraction teams for the Company [...]
Terra Tech Corp. Granted Two Permits to Open Cannabis Dispensaries in Santa Ana, California
24/07/2018
New permits for Dyer Road and Carnegie Avenue will allow Company to expand its presence in Orange County IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Terra Tech Corp . (OTCQX:TRTC), (“Terra Tech” or the “Company”) [...]
Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference
24/07/2018
LONDON, July 24, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Bespoke Extracts Announces Uplisting to OTCQB Exchange
24/07/2018
SUNNY ISLES, Fla., July 24, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, today announced that its common stock has been [...]
Wildflower Signs Letter of Intent to Acquire Leading Holistic Wellness Brand in New York
24/07/2018
VANCOUVER, British Columbia, July 24, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE:SUN) (the “Company”) is pleased to announce it has signed a Letter of Intent (“LOI”) for the acquisition Evolver Holdings Corp [...]
RedHill Biopharma Enrolls 400th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection
24/07/2018
400 of the planned total of 444 patients have been enrolled in the ongoing confirmatory U.S. Phase III study with TALICIA ® for H. pylori infection (ERADICATE Hp2) RedHill expects to complete enrollment in the Phase III [...]
Princeton Facial Plastic Surgeon on Revolutionary Cosmetic Injectable Aid OcuMend
24/07/2018
Eugenie Brunner, MD discusses the benefits of the OcuMend nanotechnology gel patch after cosmetic injectable treatment, revealing patients can reduce or eliminate post-procedure bruising and swelling PRINCETON, N.J., [...]
Achaogen to Host Conference Call and Webcast of Second Quarter 2018 Financial Results on August 6, 2018
24/07/2018
SOUTH SAN FRANCISCO, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant ( [...]
Allakos Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
24/07/2018
SAN CARLOS, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the treatment of various eosinophil and mast cell [...]
Coherus BioSciences to Report Second Quarter 2018 Financial Results on August 8th
24/07/2018
REDWOOD CITY, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that its second quarter 2018 financial results will be released after market close on Wednesday, August 8 [...]
scPharmaceuticals Announces Appointment of Two New Directors
24/07/2018
BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of [...]
Inovio Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 7, 2018
24/07/2018
PLYMOUTH MEETING, Pa., July 24, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it will host a conference call and live webcast to report its 2018 second quarter financial results [...]
Cue Biopharma Appoints Bethany Mancilla as Chief Business Officer and Senior Vice President
24/07/2018
Mancilla Brings Broad Immunotherapy Business Development and Biopharmaceutical Industry Experience CAMBRIDGE, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ:CUE) a next-generation immunotherapy [...]
7 Hills Pharma Appoints Lionel D. Lewis as Chief Medical Officer
24/07/2018
HOUSTON, July 24, 2018 (GLOBE NEWSWIRE) -- 7 Hills Pharma, a privately-held immunotherapy company focused on development of novel tumor-targeting cell adhesion agents, today announced the appointment of Lionel D. Lewis [...]
Biotricity Completes Alpha Version of Deep Data Diagnostic Solution
24/07/2018
Biotricity is Testing its Deep Data and AI Technology, to be implemented in planned Bioflux 2.0, for Improved Patient Outcomes and Call Center Efficiency while Reducing Costs and Diagnostic Time REDWOOD CITY, Calif., [...]
HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7
24/07/2018
TUCSON, Ariz., July 24, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it will report [...]
Emerald Health Therapeutics Signs Cannabis Supply Memorandum of Understanding with British Columbia Liquor Distribution Branch
24/07/2018
VICTORIA, British Columbia, July 24, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (“Emerald”) has signed a Memorandum of Understanding ("MOU") with the British Columbia Liquor [...]

Pages